High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease

Since the pioneering work of John Gofman in the 1950s, our understanding of high density lipoprotein cholesterol (HDL-C) and its relationship to coronary heart disease (CHD) has grown substantially. Numerous clinical trials since the Framingham Study in 1977 have demonstrated an inverse relationship...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapur, Navin K, Ashen, Dominique, Blumenthal, Roger S
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464766/
https://www.ncbi.nlm.nih.gov/pubmed/18629371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464766/
https://www.ncbi.nlm.nih.gov/pubmed/18629371

Ejemplares similares